|
See related Norvir soft-gelatin caps information |
|
|
|
Manufacturer |
Abbott |
|
Distributor |
Hong Kong: Zuellig/Macau: The Glory Medicina |
|
Contents |
Ritonavir |
|
Indications |
In combination w/ other antiretroviral agents for the treatment of HIV infection.
Click to view Norvir detailed prescribing infomation |
|
Dosage |
Adult 600 mg bd. Start at no <300 mg bd & increased at 2-3 day intervals by 100 mg bd. Childn 350-400 mg/m2 bd, should not exceed 600 mg bd. Start at 250 mg/m2 increased at 2-3 day intervals by 50 mg/m2 bd.
Click to view Norvir detailed prescribing infomation |
|
Overdosage |
View Norvir overdosage for action to be taken in the event of an overdose. |
|
Administration |
Should be taken with food |
|
Contraindications |
Co-administration w/ drugs metabolised by CYP3A which can cause serious &/or life-threatening reactions, including alfuzosin HCl, amiodarone, bepridil, flecainide, propafenone, quinidine, astemizole, terfenadine, dihydroergotamine, ergonovine, ergotamine, methylergonovine, cisapride, pimozide, midazolam, triazolam.
Click to view Norvir detailed prescribing infomation |
|
Warnings |
For additional cautionary notes to warn of the potential risk of using the medicine... click to view Norvir detailed prescribing infomation |
|
Special Precautions |
Hepatic impairment, haemophilia type A & B, DM, hyperglycemia, pancreatitis. Perform triglyceride & cholesterol testing prior to initiating therapy & at periodic intervals during therapy. Pregnancy & lactation.
Click to view Norvir detailed prescribing infomation |
|
Adverse Drug Reactions |
Asthenia, GI & neurological disturbances including nausea, diarrhea, vomiting, anorexia, abdominal pain, taste perversion & circumoral & peripheral paresthesias.
View ADR Monitoring Form |
|
Drug Interactions |
Indinavir, saquinavir, didanosine, meperidine, disulfiram/metronidazole, warfarin, desipramine, trazodone, ketoconazole, clarithromycin, rifabutin, rifampicin, theophylline, sildenafil, fluticasone, methadone, OC.
View more drug interactions with Norvir |
|
Pregnancy Category (US FDA) |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
|
Storage |
View Norvir storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Norvir description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Norvir mechanism of action for pharmacodynamics and pharmacokinetics details. |
